These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 20309922)
21. Pharmacogenomics in the Americas: the impact of genetic admixture. Suarez-Kurtz G; Pena SD Curr Drug Targets; 2006 Dec; 7(12):1649-58. PubMed ID: 17168840 [TBL] [Abstract][Full Text] [Related]
22. Genetic ancestry plays a central role in population pharmacogenomics. Yang HC; Chen CW; Lin YT; Chu SK Commun Biol; 2021 Feb; 4(1):171. PubMed ID: 33547344 [TBL] [Abstract][Full Text] [Related]
23. Pharmacogenetics in primary care: the promise of personalized medicine and the reality of racial profiling. Hunt LM; Kreiner MJ Cult Med Psychiatry; 2013 Mar; 37(1):226-35. PubMed ID: 23264029 [TBL] [Abstract][Full Text] [Related]
24. Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications. Zhang F; Finkelstein J Pharmgenomics Pers Med; 2019; 12():107-123. PubMed ID: 31308725 [TBL] [Abstract][Full Text] [Related]
25. Will personalized medicine challenge or reify categories of race and ethnicity? Rajagopalan R; Fujimura JH Virtual Mentor; 2012 Aug; 14(8):657-63. PubMed ID: 23351323 [No Abstract] [Full Text] [Related]
26. Pharmacogenetics, race, and ethnicity: social identities and individualized medical care. Foster MW; Sharp RR; Mulvihill JJ Ther Drug Monit; 2001 Jun; 23(3):232-8. PubMed ID: 11360031 [TBL] [Abstract][Full Text] [Related]
27. Harmonizing Genetic Ancestry and Self-identified Race/Ethnicity in Genome-wide Association Studies. Fang H; Hui Q; Lynch J; Honerlaw J; Assimes TL; Huang J; Vujkovic M; Damrauer SM; Pyarajan S; Gaziano JM; DuVall SL; O'Donnell CJ; Cho K; Chang KM; Wilson PWF; Tsao PS; ; Sun YV; Tang H Am J Hum Genet; 2019 Oct; 105(4):763-772. PubMed ID: 31564439 [TBL] [Abstract][Full Text] [Related]
28. Genetic influences on health: does race matter? Bamshad M JAMA; 2005 Aug; 294(8):937-46. PubMed ID: 16118384 [TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetics in diverse ethnic populations--implications for drug discovery and development. McCarthy LC; Davies KJ; Campbell DA Pharmacogenomics; 2002 Jul; 3(4):493-506. PubMed ID: 12164773 [TBL] [Abstract][Full Text] [Related]
30. Race, risk, and recreation in personal genomics: the limits of play. Lee SS Med Anthropol Q; 2013 Dec; 27(4):550-69. PubMed ID: 24214161 [TBL] [Abstract][Full Text] [Related]
31. Pharmacogenetic considerations for HIV treatment in different ethnicities: an update. Neary M; Owen A Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1169-1181. PubMed ID: 28994310 [TBL] [Abstract][Full Text] [Related]
32. Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity. Chan SL; Jin S; Loh M; Brunham LR Pharmacogenomics; 2015; 16(10):1161-78. PubMed ID: 25978008 [TBL] [Abstract][Full Text] [Related]
33. Influence of ethnicity on response to asthma drugs. Cazzola M; Rogliani P; Sanduzzi A; Matera MG Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1089-97. PubMed ID: 25995058 [TBL] [Abstract][Full Text] [Related]
34. Genome-wide approaches in pharmacogenomics: heritability estimation and pharmacoethnicity as primary challenges. Gamazon ER; Perera M Pharmacogenomics; 2012 Jul; 13(10):1101-4. PubMed ID: 22909197 [No Abstract] [Full Text] [Related]
35. Global pharmacogenetics: giving the genome to the masses. Marsh S; Van Booven DJ; McLeod HL Pharmacogenomics; 2006 Jun; 7(4):625-31. PubMed ID: 16753009 [TBL] [Abstract][Full Text] [Related]
36. Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity. Cservenka A; Yardley MM; Ray LA Am J Addict; 2017 Aug; 26(5):516-525. PubMed ID: 28134463 [TBL] [Abstract][Full Text] [Related]
37. Mapping genes that predict treatment outcome in admixed populations. Baye TM; Wilke RA Pharmacogenomics J; 2010 Dec; 10(6):465-77. PubMed ID: 20921971 [TBL] [Abstract][Full Text] [Related]
38. Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation. Wheeler HE; Dolan ME Pharmacogenomics; 2012 Jan; 13(1):55-70. PubMed ID: 22176622 [TBL] [Abstract][Full Text] [Related]
39. Ethnically diverse pluripotent stem cells for drug development. Fakunle ES; Loring JF Trends Mol Med; 2012 Dec; 18(12):709-16. PubMed ID: 23142148 [TBL] [Abstract][Full Text] [Related]
40. Race, ancestry, and genes: implications for defining disease risk. Kittles RA; Weiss KM Annu Rev Genomics Hum Genet; 2003; 4():33-67. PubMed ID: 14527296 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]